CEO MESSAGE

We aim to contribute the 「Better Life」 and become trusted company by the local community through continuous growth with the bio industry. Ajinomoto Genexine Co., Ltd. is an affiliate of Ajinomoto Group which was established as a joint venture by Ajinomoto Co., Inc. and Genexine Inc. in Incheon Free Economic Zone in November 2012. We are specialized in providing cell culture media and related products for biopharmaceuticals. Biopharmaceuticals have been shown to have significant therapeutic effects against rare diseases and intractable diseases, which have been difficult to treat with small molecule drugs, and thus are contributing to better lives. In case of antibody pharmaceuticals, in particular, are expected to undergo dramatic advances due to their excellent therapeutic effects and low chances of side effects. Antibody pharmaceuticals are mostly produced by animal cell cultures with amino acids as the primary constituent, and cell culture media are used in the cell cultivation process. As a member of Ajinomoto Group, the world’s No. 1 amino acid maker, we will make earnest efforts to create customer value by meeting customer needs, based on our knowledge in the study of nutrition, mixing techniques and technologies related to amino acids, using high-quality amino acids as our key ingredients. We aim to contribute to better lives and become a company who trusted by the local community through continuous growth with the advancement of the bio industry. Kiyohiko Nishi, President of Ajinomoto Genexine Co., Ltd.